Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites.

The genetic and phenotypic properties of cells which ultimately give rise to carcinoma of the lung are not well defined in part because of unavailability of preneoplastic cells from well-characterized dysplastic sites. In order to expand bronchial epithelial cell populations from patients at high risk for lung cancer, endobronchial biopsy specimens were explanted onto collagen- and fibronectin-coated dishes and cultured in serum-free, chemically defined media. One hundred forty-nine biopsy pairs were obtained from smokers and from healthy volunteers for culture and histologic evaluation. The histologic appearances of mucosa adjacent to the site of the cultured biopsies ranged from normal through varying degrees of noninvasive squamous dysplasia to invasive carcinoma. Confluent monolayers of pure epithelial cells were obtained from 68% of the cultured explants. Sites exhibiting high-grade dysplasia were 51% more likely to yield successful cultures than sites exhibiting normal histology (13 of 14 cultures successful versus 52 of 83 cultures successful, P < 0.02). Cultures had a maximum proliferative life span of 81 days and none of the cultures spontaneously became immortalized. Immunolabeling studies revealed that all cultured epithelial cells, regardless of the in situ histologic appearances of the mucosa at the biopsy site, strongly expressed keratin and epidermal growth factor receptor, weakly expressed transferrin receptor and human folate receptor, and were negative for neural cell adhesion molecule and human leukocyte antigen DR (HLADR). Ploidy and karyotypic analyses were performed in a limited number of explants from normal and dysplastic sites and all were found to be diploid without karyotypic abnormality. We conclude that pure bronchial epithelial cell populations can be routinely expanded from histologically normal and dysplastic sites by tissue culture of biopsy explants and that the expanded cell populations may represent a library of normal and preneoplastic cells which are suitable for immunophenotypic, ploidy, genetic, or functional analyses.

[1]  D. Carbone,et al.  The molecular genetics of lung cancer. , 2008, Advances in internal medicine.

[2]  A. Jetten,et al.  Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-gamma in vitro. , 1994, American journal of respiratory cell and molecular biology.

[3]  A E Profio,et al.  Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. , 1993, The Journal of thoracic and cardiovascular surgery.

[4]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[5]  B Palcic,et al.  Detection of dysplasia and carcinoma in situ by ratio fluorometry. , 1992, The American review of respiratory disease.

[6]  J. Bergh,et al.  Characterization of the submicroscopic deletion in the small‐cell lung carcinoma (SCLC) cell line U2020 , 1992, Genes, chromosomes & cancer.

[7]  S. Kelsen,et al.  A technique to harvest viable tracheobronchial epithelial cells from living human donors. , 1992, American journal of respiratory cell and molecular biology.

[8]  A. Ullrich,et al.  Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. , 1990, Cancer research.

[9]  C. Harris,et al.  Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Montag,et al.  Immunophenotype of small cell lung carcinoma: Expression of NKH‐1 and transferrin receptor and absence of most myeloid antigens , 1988, Cancer.

[11]  C. Harris,et al.  Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. , 1988, Cancer research.

[12]  R. Souhami,et al.  ANTIGENS OF SMALL-CELL LUNG CANCER First International Workshop , 1987, The Lancet.

[13]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[14]  C. Harris,et al.  Keratin proteins in human lung carcinomas. Combined use of morphology, keratin immunocytochemistry, and keratin immunoprecipitation. , 1984, The American journal of pathology.

[15]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  S. Boyce,et al.  Rapid clonal growth and serial passage of human diploid fibroblasts in a lipid-enriched synthetic medium supplemented with epidermal growth factor, insulin, and dexamethasone. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[17]  O. Auerbach,et al.  Development of carcinoma of the lung as reflected in exfoliated cells , 1974, Cancer.

[18]  P. Bunn,et al.  New anti‐lung‐cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[19]  P. Rabbitts Genetic changes in the development of lung cancer. , 1994, British medical bulletin.

[20]  B Palcic,et al.  Detection and localization of early lung cancer by imaging techniques. , 1993, Chest.